Literature DB >> 31618432

Passive and Active Surveillance for Ixodes scapularis (Acari: Ixodidae) in Saskatchewan, Canada.

Neil B Chilton1, Philip S Curry2, L Robbin Lindsay3, Kateryn Rochon4, Timothy J Lysyk, Shaun J Dergousoff5.   

Abstract

Passive and active surveillance for the blacklegged tick, Ixodes scapularis Say, in the Canadian province of Saskatchewan was conducted over a 9-yr period (2009-2017). More than 26,000 ixodid ticks, representing 10 species, were submitted through passive surveillance. Most (97%) of these were the American dog tick, Dermacentor variabilis (Say). Of the 65 I. scapularis adults submitted, 75% were collected from dogs. Infection rates of Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti in I. scapularis were 12%, 8%, and 0%, respectively. Although the I. scapularis submitted by passive surveillance were collected from five of seven ecoregions in central and southern Saskatchewan, they were most frequent in the Moist Mixed Grassland and Aspen Parklands. In contrast, no I. scapularis were collected from the extensive field sampling conducted at multiple sites in different ecoregions across the province. Hence, there is no evidence of I. scapularis having established a breeding population in Saskatchewan. Nonetheless, continued surveillance for blacklegged ticks is warranted given their important role as a vector of medically and veterinary important pathogens, and because they have recently become established across much of the southern portions of the neighboring province of Manitoba. © Her Majesty the Queen in Right of Canada, as represented by the Minister of Agriculture and Agri-Food Canada, 2019.

Entities:  

Keywords:  zzm321990 Anaplasmazzm321990 ; zzm321990 Borreliazzm321990 ; active sampling; blacklegged tick; passive surveillance

Year:  2020        PMID: 31618432     DOI: 10.1093/jme/tjz155

Source DB:  PubMed          Journal:  J Med Entomol        ISSN: 0022-2585            Impact factor:   2.278


  7 in total

1.  Reproductive output and larval survival of American dog ticks (Dermacentor variabilis) from a population at the northern distributional limit.

Authors:  Chulantha P Diyes; Shaun J Dergousoff; Matthew E M Yunik; Neil B Chilton
Journal:  Exp Appl Acarol       Date:  2021-01-04       Impact factor: 2.132

2.  Repellent and acaricidal activities of basil (Ocimum basilicum) essential oils and rock dust against Ixodes scapularis and Dermacentor variabilis ticks.

Authors:  Haozhe V Wang; Laura J Pickett; Nicoletta Faraone
Journal:  Exp Appl Acarol       Date:  2022-03-01       Impact factor: 2.132

3.  Surveillance of Babesia odocoilei in wild and farmed cervid populations of Saskatchewan, Canada.

Authors:  Hilary J Burgess; Kimberly M Pattullo; Crystal A Rainbow; Marnie Zimmer; Betty P Lockerbie; Trent K Bollinger
Journal:  Can Vet J       Date:  2022-07       Impact factor: 1.075

4.  Monitoring Trends in Distribution and Seasonality of Medically Important Ticks in North America Using Online Crowdsourced Records from iNaturalist.

Authors:  Benjamin Cull
Journal:  Insects       Date:  2022-04-22       Impact factor: 3.139

Review 5.  Benefits and Drawbacks of Citizen Science to Complement Traditional Data Gathering Approaches for Medically Important Hard Ticks (Acari: Ixodidae) in the United States.

Authors:  Lars Eisen; Rebecca J Eisen
Journal:  J Med Entomol       Date:  2021-01-12       Impact factor: 2.278

6.  Public perceptions of Lyme disease and climate change in southern Manitoba, Canada: making a case for strategic decoupling of climate and health messages.

Authors:  Laura Cameron; Rhéa Rocque; Kailey Penner; Ian Mauro
Journal:  BMC Public Health       Date:  2021-03-30       Impact factor: 3.295

Review 7.  Epidemiology of ticks submitted from human hosts in Alberta, Canada (2000-2019).

Authors:  Jamil N Kanji; Abraam Isaac; Daniel Gregson; Monika Mierzejewski; Danny Shpeley; Pauline Tomlin; Michael Groeschel; L Robbin Lindsay; Lisa Lachance; Kinga Kowalewska-Grochowska
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.